Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionEstabrook Capital Management
Latest Disclosed Ownership1,216 shares
Latest Disclosed Value $ 169,474
Estabrook Capital Management reports 1.33% increase in ownership of GILD / Gilead Sciences, Inc.

On May 14, 2026 - Estabrook Capital Management filed a 13F-HR form disclosing ownership of 1,216 shares of Gilead Sciences, Inc. (CH:GILD) valued at $169,474 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 1,200 shares of Gilead Sciences, Inc.. This represents a change in shares of 1.33% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F GILEAD SCIENCES INC COM COMMON 375558103 1,216 16 1.33 169 14.97 0.0247
2026-02-13 2025-12-31 13F GILEAD SCIENCES INC COM COMMON 375558103 1,200 0 0.00 147 10.53 0.0216
2025-11-10 2025-09-30 13F GILEAD SCIENCES INC COM COMMON 375558103 1,200 0 0.00 133 0.00 0.0194
2025-08-13 2025-06-30 13F GILEAD SCIENCES INC COM COMMON 375558103 1,200 0 0.00 133 -0.75 0.0205
2025-05-14 2025-03-31 13F GILEAD SCIENCES INC COM COMMON 375558103 1,200 0 0.00 134 21.82 0.0217
2025-02-13 2024-12-31 13F GILEAD SCIENCES INC COM COMMON 375558103 1,200 0 0.00 111 10.00 0.0171
2024-11-13 2024-09-30 13F GILEAD SCIENCES INC COM COMMON 375558103 1,200 0 0.00 101 21.95 0.0150
2024-08-13 2024-06-30 13F GILEAD SCIENCES INC COM COMMON 375558103 1,200 0 0.00 82 -5.75 0.0127
2024-05-14 2024-03-31 13F GILEAD SCIENCES INC COM COMMON 375558103 1,200 0 0.00 88 -10.31 0.0136
2024-02-13 2023-12-31 13F GILEAD SCIENCES INC COM COMMON 375558103 1,200 0 0.00 97 8.99 0.0159
2023-11-13 2023-09-30 13F GILEAD SCIENCES INC COM COMMON 375558103 1,200 0 0.00 90 -3.26 0.0158
2023-08-11 2023-06-30 13F GILEAD SCIENCES INC COM COMMON 375558103 1,200 0 0.00 92 -7.07 0.0154
2023-05-12 2023-03-31 13F GILEAD SCIENCES INC COM COMMON 375558103 1,200 0 0.00 100 -3.88 0.0173
2023-02-13 2022-12-31 13F GILEAD SCIENCES INC COM COMMON 375558103 1,200 0 0.00 103 39.19 0.0177
2022-11-14 2022-09-30 13F GILEAD SCIENCES INC COM COMMON 375558103 1,200 0 0.00 74 0.00 0.0138
2022-08-15 2022-06-30 13F GILEAD SCIENCES INC COM COMMON 375558103 1,200 0 0.00 74 4.23 0.0127
2022-05-13 2022-03-31 13F GILEAD SCIENCES INC COM COMMON 375558103 1,200 0 0.00 71 -18.39 0.0105
2022-02-11 2021-12-31 13F GILEAD SCIENCES INC COM COMMON 375558103 1,200 1,200 87 0.0124
2017-11-09 2017-09-30 13F GILEAD SCIENCES INC COM COMMON 375558103 0 -350 -100.00 0 -100.00
2017-08-10 2017-06-30 13F GILEAD SCIENCES INC COM COMMON 375558103 350 -3,290 -90.38 25 -90.28 0.0039
2017-05-12 2017-03-31 13F GILEAD SCIENCES INC COM COMMON 375558103 3,640 -300 -7.61 247 -12.41 0.0387
2017-02-14 2016-12-31 13F GILEAD SCIENCES INC COM COMMON 375558103 3,940 -1,655 -29.58 282 -36.20 0.0442
2016-11-14 2016-09-30 13F GILEAD SCIENCES INC COM COMMON 375558103 5,595 -664 -10.61 443 -15.33 0.0650
2016-08-12 2016-06-30 13F GILEAD SCIENCES INC COM COMMON 375558103 6,259 200 3.30 522 -6.12 0.0782
2016-05-11 2016-03-31 13F GILEAD SCIENCES INC COM COMMON 375558103 6,059 2,310 61.62 557 46.70 0.0824
2016-02-08 2015-12-31 13F GILEAD SCIENCES INC COM COMMON 375558103 3,749 1,050 38.90 379 43.02 0.0549
2015-11-12 2015-09-30 13F GILEAD SCIENCES INC COM COMMON 375558103 2,699 1,235 84.36 265 54.97 0.0382
2015-08-11 2015-06-30 13F GILEAD SCIENCES INC COM COMMON 375558103 1,464 0 0.00 171 19.58 0.0212
2015-05-14 2015-03-31 13F GILEAD SCIENCES INC COM COMMON 375558103 1,464 700 91.62 144 98.61 0.0168
2015-02-11 2014-12-31 13F GILEAD SCIENCES INC COM COMMON 375558103 764 0 0.00 72 -11.11 0.0079
2014-11-13 2014-09-30 13F GILEAD SCIENCES INC COM COMMON 375558103 764 0 0.00 81 28.57 0.0087
2014-08-11 2014-06-30 13F GILEAD SCIENCES INC COM COMMON 375558103 764 0 0.00 63 16.67 0.0065
2014-05-13 2014-03-31 13F GILEAD SCIENCES INC COM COMMON 375558103 764 0 0.00 54 -5.26 0.0055
2014-02-13 2013-12-31 13F GILEAD SCIENCES INC COM COMMON 375558103 764 0 0.00 57 18.75 0.0059
2013-11-14 2013-09-30 13F GILEAD SCIENCES INC COM COMMON 375558103 764 0 0.00 48 23.08 0.0052
2013-08-15 2013-06-30 13F GILEAD SCIENCES INC COM COMMON 375558103 764 764 39 0.0041
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.